Theravance Biopharma TBPH Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's change in AP?
- Theravance Biopharma (TBPH) reported change in AP of -$1.47M in Q1 2026.
- How has Theravance Biopharma's change in AP changed year-over-year?
- Theravance Biopharma's change in AP decreased by 984.3% year-over-year, from $166K to -$1.47M.
- What is the long-term trend for Theravance Biopharma's change in AP?
- Over 2 years (2021 to 2025), Theravance Biopharma's change in AP has grown at a -69.6% compound annual growth rate (CAGR), from -$3.53M to $326K.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.